MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

The study is the first set of global estimates directly linking diabetes prevalence with treatment coverage over a ...

Type 1 diabetes is a condition where the pancreas produces ... do so by wiping out the population of white blood cells…Drugs ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Researchers at the University of Copenhagen have identified a promising new drug target for weight loss which could revolutionise treatment for millions of people with obesity and type 2 diabetes. The ...

Researchers from the University of Copenhagen have discovered a new weight loss drug target that works without causing nausea ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Francis Howell’s current fund balance was insufficient to meet growing ... Francis Howell’s health plan will continue to ...

In recent years, the medical community has been reevaluating traditional approaches to managing type 2 diabetes. A groundbreaking study has shed new light on ...

The discovery could lead to a new treatment for millions of people with obesity and type 2 diabetes who do not respond well ...